Royal Bank of Canada
ELOS

Royal Bank of Canada’s Syneron Medical Ltd ELOS Stock Holding History

Royal Bank of Canada’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-400
Closed -$4K – 7323
2017
Q2 		$4K Sell
400
-2
-0.5% -$22 ﹤0.01% 6155
2017
Q1 		$4K Buy
402
+2
+0.5% +$19 ﹤0.01% 6320
2016
Q4 		$3K Hold
400
– – ﹤0.01% 6443
2016
Q3 		$3K Hold
400
– – ﹤0.01% 6138
2016
Q2 		$3K Hold
400
– – ﹤0.01% 6109
2016
Q1 		$3K Sell
400
-28
-7% -$201 ﹤0.01% 6090
2015
Q4 		$3K Buy
428
+28
+7% +$214 ﹤0.01% 6320
2015
Q3 		$3K Hold
400
– – ﹤0.01% 6343
2015
Q2 		$4K Hold
400
– – ﹤0.01% 6293
2015
Q1 		$5K Hold
400
– – ﹤0.01% 5761
2014
Q4 		$4K Hold
400
– – ﹤0.01% 5878
2014
Q3 		$4K Hold
400
– – ﹤0.01% 5708
2014
Q2 		$4K Hold
400
– – ﹤0.01% 5631
2014
Q1 		$5K Sell
400
-1,000
-71% -$11.8K ﹤0.01% 5588
2013
Q4 		$17K Buy
+1,400
New +$14.5K ﹤0.01% 5322
2013
Q3 		– Sell
-1,394
Closed -$12K – 6388
2013
Q2 		$12K Buy
+1,394
New +$12.5K ﹤0.01% 5221

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Royal Bank of Canada's ELOS Position: Q3 2017 in Review

Royal Bank of Canada sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 400 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in ELOS in Q2 2013 and held it in 16 quarters. The position peaked at $17K in Q4 2013. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Royal Bank of Canada reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 400 Syneron Medical Ltd shares in Q3 2017, an estimated $4K.
  • Royal Bank of Canada first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 16 quarters.
  • Royal Bank of Canada's Syneron Medical Ltd position peaked at $17K in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Royal Bank of Canada's 13F filing for Q3 2017, filed 14 Nov 2017.